Literature DB >> 20684832

Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.

Lindsay M Reynolds1, Gavin P Reynolds.   

Abstract

There is substantial evidence for the involvement of the hippocampus and subcortical regions in the neuropathology of schizophrenia. Deficits of N-acetylaspartate (NAA) have been found in schizophrenia and bipolar disorder which may reflect neuronal loss and/or dysfunction. N-acetylaspartylglutamate (NAAG) is the most abundant peptide transmitter in the mammalian nervous system. It is an agonist at presynaptic metabotropic glutamate receptors mGluR3, inhibiting glutamate release. NAA and NAAG and were measured in hippocampal, striatal, amygdala and cingulate gyrus regions of human postmortem tissue from controls and subjects with schizophrenia, bipolar disorder and major depressive disorder. There are significant deficits in hippocampal NAA concentrations in all patient groups. In the amygdala there are significant NAA deficits in schizophrenia and depression and significant deficits of NAAG in the amygdala in the depression group. The deficits in NAA reported in this study confirm the importance of hippocampal and other subcortical structures in the neuropathology of the major psychiatric disorders. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684832     DOI: 10.1016/j.jpsychires.2010.05.001

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  13 in total

Review 1.  In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.

Authors:  S Andrea Wijtenburg; Shaolin Yang; Bernard A Fischer; Laura M Rowland
Journal:  Neurosci Biobehav Rev       Date:  2015-01-19       Impact factor: 8.989

2.  Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.

Authors:  Javier de Diego-Adeliño; Maria J Portella; Beatriz Gómez-Ansón; Olga López-Moruelo; Maria Serra-Blasco; Yolanda Vives; Dolors Puigdemont; Rosario Pérez-Egea; Enric Álvarez; Víctor Pérez
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

Review 3.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

4.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

5.  Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

6.  The relationship between the alterations in metabolite levels in the dorsolateral prefrontal cortex and clinical symptoms of patients with first-episode schizophrenia: a one year follow-up study.

Authors:  Manli Huang; Wuqiu Guo; Shaojia Lu; Fen Pan; Jinkai Chen; Jianbo Hu; Shaohua Hu; Weijuan Xu; Desheng Shang; Yi Xu
Journal:  Oncotarget       Date:  2018-01-04

7.  Striatal Shati/Nat8l-BDNF pathways determine the sensitivity to social defeat stress in mice through epigenetic regulation.

Authors:  Hajime Miyanishi; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Neuropsychopharmacology       Date:  2021-06-07       Impact factor: 8.294

8.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

9.  Striatal N-Acetylaspartate Synthetase Shati/Nat8l Regulates Depression-Like Behaviors via mGluR3-Mediated Serotonergic Suppression in Mice.

Authors:  Yoshiaki Miyamoto; Noriyuki Iegaki; Kequan Fu; Yudai Ishikawa; Kazuyuki Sumi; Sota Azuma; Kyosuke Uno; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

10.  The neurobiology of wellness: 1H-MRS correlates of agency, flexibility and neuroaffective reserves in healthy young adults.

Authors:  Tara L White; Meghan A Gonsalves; Ronald A Cohen; Ashley D Harris; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Eric C Porges; Damon G Lamb; Adam J Woods; Cara B Borja
Journal:  Neuroimage       Date:  2020-10-27       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.